Rituximab in minimal change disease and focal segmental glomerulosclerosis

Nephrol Dial Transplant. 2021 May 27;36(6):983-985. doi: 10.1093/ndt/gfz205.

Authors

Andreas Kronbichler¹, Philipp Gauckler¹, Annette Bruchfeld²

Affiliations

¹ Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
² Department of Clinical Sciences Interventions and Technology (CLINTEC), Division of Renal Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

PMID: 31580445
DOI: 10.1093/ndt/gfz205

No abstract available